adults without diabetes used a GLP-1 (drug) in 2022, wrote the research team led by Michelle Dowsey, an epidemiologist with the University of Melbourne in Australia.GLP-1 drugs mimic the GLP-1 hormone, which helps control insulin and blood sugar levels, decreases appetite and slows digestion of food.Initially approved to control diabetes, the drugs effectiveness at helping people lose weight led to their later approval for that purpose as well.For this study, researchers analyzed U.S
Samples may be rejected if the urine is too dilute
Inclusion criteria included adult patients with confirmed T2DM receiving any GLP-1RA, with the outcomes focused on gastrointestinal adverse events such as nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite
Among the common side effects these drugs share are gastrointestinal ones, such as nausea, vomiting, constipation, diarrhea, and stomach or abdominal pain
However, it is an invasive procedure with associated surgical risks, a longer recovery period, and requires lifelong nutritional and lifestyle changes
This initial research spurred further investigations into GHRP activity, with subsequent studies investigating various GHRPs and their effects on test subjects
